相关实验视频
Updated: Jan 7, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
27.7K
在印度的学龄儿童中肥胖的流行:综合系统性审查,元分析和空间分析
C Deepa1, Kalesh M Karun1, Amitha Puranik2
1Department of Health Systems Research, ICMR - National Institute of Traditional Medicine, Nehru Nagar, Belagavi, Karnataka, India.
概括
在印度,儿童肥胖影响了6.97%的学龄儿童,北方地区的患病率最高. 这一系统性审查强调了一个令人担忧的上升趋势,需要有针对性的公共卫生干预措施.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 儿科 儿科 儿科
背景情况:
- 儿童肥胖是印度和其他发展中国家的重大公共卫生问题.
- 现有研究报告说,印度学童的肥胖率不同.
- 了解国家和州级的分布对于有效的预防至关重要.
研究的目的:
- 估计印度上学儿童中肥胖的综合流行率.
- 分析儿童肥胖在印度各地区的地理分布.
- 为了识别随着时间的推移,儿童肥胖患病率的趋势.
主要方法:
- 横截面研究 (1995-2023) 的系统审查和元分析.
- 数据取自PubMed,Scopus和Web of Science,由两个独立的评论员进行.
- 由于异质性很高,使用随机效应模型;进行空间和累积元分析.
主要成果:
- 印度学校儿童中肥胖的总体综合患病率为6.97%.
- 北部地区患病率最高 (8.58%),中部地区患病率最低 (5.63%).
- 累积分析显示,多年来肥胖患病率的持续上升趋势.
结论:
- 这一元分析提供了关于印度儿童肥胖的范围和地理模式的关键数据.
- 调查结果强调,需要制定特定区域和国家战略,以应对日益增长的儿童肥胖.
- 早期干预至关重要,以防止儿童肥胖在成年后的长期健康后果.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
218
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
218
Prevalence and Incidence
1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Drug Dosing: Obese Patients
195
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
195
Bias in Epidemiological Studies
1.2K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.2K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
153
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
153

